Shruthi Pulimamidi

Researcher

Last publication 2024 Last refreshed 2026-04-01

faculty

2 h-index 12 pubs 20 cited

Biography and Research Information

OverviewAI-generated summary

Shruthi Pulimamidi's research has focused on investigating various therapeutic interventions and their efficacy. Her work includes a retrospective review and comparison of Onabotulinum toxin A and incobotulinum toxin A for chronic migraine treatment, with a recent publication in 2024. Pulimamidi has also examined the efficacy and safety of Kcentra versus Feiba in patients with intracerebral hemorrhage secondary to oral anticoagulants. Her publications also address the management of chronic diseases through dietary interventions such as intermittent fasting and the ketogenic diet, as well as the impact of early mobilization protocols in acute ischemic stroke patients. Additionally, her research has explored outcomes in patients with diabetic ketoacidosis and heart failure, and the development of Takotsubo stress cardiomyopathy during acute coronavirus infection.

Metrics

  • h-index: 2
  • Publications: 12
  • Citations: 20

Selected Publications

  • A Retrospective Comparison of Onabotulinum Toxin A and Incobotulinum Toxin A in Terms of Efficacy, Tolerability, Duration of Effect, and Pain on Injection Administration Site for the Treatment of Chronic Migraine (2024)
    1 citation DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

41 Collaborators 13 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics